Advertisement

Topics

FDA locks down import from 3 Indian IPCA facilities

05:32 EDT 21 Jun 2017 | Pharmafile

More drama in the Indian pharma sector as the FDA announces it has enforced a ban on the import of drug products manufactured at three sites owned by IPCA Laboratories, preventing them from entering the US.

read more

Original Article: FDA locks down import from 3 Indian IPCA facilities

NEXT ARTICLE

More From BioPortfolio on "FDA locks down import from 3 Indian IPCA facilities"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...